Literature DB >> 31352553

Atypical Clinical Manifestations of Cerebral Amyloid Angiopathy.

Carolyn Akers1, Lealani May Y Acosta1, Ciaran Considine1, Daniel Claassen1, Howard Kirshner1, Matthew Schrag2.   

Abstract

PURPOSE: Cerebral amyloid angiopathy is a vasculopathy caused by β-amyloid deposition in cerebral arterioles and capillaries. It is closely linked to Alzheimer's disease and predisposes elderly patients to intracerebral hemorrhage, transient focal neurological episodes, and cognitive impairment. Because of a predilection for symptomatic hemorrhage, particularly in the frontal lobes, cerebral amyloid angiopathy may also cause a dysexecutive syndrome. RECENT
FINDINGS: In this case series, we describe presentations of classic clinical dementia syndromes which are not are widely thought to be associated with cerebral amyloid angiopathy, namely logopenic variant primary progressive aphasia (n = 3), normal pressure hydrocephalus (n = 3), and Lewy body dementia (n = 2). In every case, after a clinical diagnosis was established, neuroimaging, brain biopsy, and/or autopsy confirmed the presence of cerebral amyloid angiopathy. Cerebral amyloid angiopathy has significant clinical implications, and its ability to mimic and/or contribute to other clinical dementia syndromes can complicate its diagnosis. This series of cases broadens the range of clinical scenarios associated with cerebral amyloid angiopathy.

Entities:  

Keywords:  Alzheimer’s disease; Aphasia; Cerebral amyloid angiopathy; Hallucinations; Hydrocephalus; Lewy body

Year:  2019        PMID: 31352553     DOI: 10.1007/s11910-019-0981-4

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  31 in total

Review 1.  Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement.

Authors:  James A R Nicoll; Masahito Yamada; Janusz Frackowiak; Bozena Mazur-Kolecka; Roy O Weller
Journal:  Neurobiol Aging       Date:  2004 May-Jun       Impact factor: 4.673

2.  Effect of cerebral amyloid angiopathy on brain iron, copper, and zinc in Alzheimer's disease.

Authors:  Matthew Schrag; Andrew Crofton; Matthew Zabel; Arshad Jiffry; David Kirsch; April Dickson; Xiao Wen Mao; Harry V Vinters; Dylan W Domaille; Christopher J Chang; Wolff Kirsch
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

3.  Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  J Neurol Sci       Date:  2004-12-22       Impact factor: 3.181

4.  Lobar distribution of cerebral microbleeds: the Rotterdam Scan Study.

Authors:  Dymph J Mesker; Mariëlle M F Poels; M Arfan Ikram; Meike W Vernooij; Albert Hofman; Henri A Vrooman; Aad van der Lugt; Monique M B Breteler
Journal:  Arch Neurol       Date:  2011-05

5.  Iron quantification of microbleeds in postmortem brain.

Authors:  Grant McAuley; Matthew Schrag; Samuel Barnes; Andre Obenaus; April Dickson; Barbara Holshouser; Wolff Kirsch
Journal:  Magn Reson Med       Date:  2010-12-16       Impact factor: 4.668

6.  Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study.

Authors:  Matthew Schrag; Grant McAuley; Justine Pomakian; Arshad Jiffry; Spencer Tung; Claudius Mueller; Harry V Vinters; E Mark Haacke; Barbara Holshouser; Daniel Kido; Wolff M Kirsch
Journal:  Acta Neuropathol       Date:  2010-03       Impact factor: 17.088

7.  Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study.

Authors:  J P Vonsattel; R H Myers; E T Hedley-Whyte; A H Ropper; E D Bird; E P Richardson
Journal:  Ann Neurol       Date:  1991-11       Impact factor: 10.422

Review 8.  Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage.

Authors:  Mark O McCarron; James A R Nicoll
Journal:  Lancet Neurol       Date:  2004-08       Impact factor: 44.182

9.  Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia.

Authors:  Wolff Kirsch; Grant McAuley; Barbara Holshouser; Floyd Petersen; Muhammad Ayaz; Harry V Vinters; Cindy Dickson; E Mark Haacke; William Britt; James Larseng; Ivan Kim; Claudius Mueller; Matthew Schrag; Daniel Kido
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

10.  Cerebral amyloid angiopathy in Lewy body disease.

Authors:  K A Jellinger; J Attems
Journal:  J Neural Transm (Vienna)       Date:  2008-02-26       Impact factor: 3.575

View more
  3 in total

1.  A Case of Cerebral Amyloid Angiopathy Presented with Cognitive Decline and Hoarding Behavior.

Authors:  Jeewon Lee; Soyoung Irene Lee; Shin Gyeom Kim; Jungbin Lee; Han Yong Jung
Journal:  Psychiatry Investig       Date:  2020-04-15       Impact factor: 2.505

Review 2.  [Current findings on the coincidence of cerebral amyloid angiopathy and Alzheimer's disease].

Authors:  R Haußmann; P Homeyer; M Donix; J Linn
Journal:  Nervenarzt       Date:  2021-10-15       Impact factor: 1.297

3.  MRI and flortaucipir relationships in Alzheimer's phenotypes are heterogeneous.

Authors:  Keith A Josephs; Nirubol Tosakulwong; Jonathan Graff-Radford; Stephen D Weigand; Marina Buciuc; Mary M Machulda; David T Jones; Christopher G Schwarz; Matthew L Senjem; Nilufer Ertekin-Taner; Kejal Kantarci; Bradley F Boeve; David S Knopman; Clifford R Jack; Ronald C Petersen; Val J Lowe; Jennifer L Whitwell
Journal:  Ann Clin Transl Neurol       Date:  2020-04-15       Impact factor: 4.511

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.